MARGARET TRAWICK: Open Payments
NPI 1770942443 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 105 payments from 16 companies in 2025. Trend: 2023 $128 · 2024 $155 · 2025 $1,866
Food & beverage: $1,866
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $292 |
| Tris Pharma Inc | 12 | $283 |
| Neurocrine BioSciences, Inc. | 13 | $246 |
| Collegium Pharmaceutical, Inc. | 15 | $204 |
| ABBVIE INC. | 18 | $171 |
| Otsuka America Pharmaceutical, Inc. | 8 | $145 |
| Almatica Pharma LLC | 4 | $85 |
| Alkermes, Inc. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
Products named: CAPLYTA, Dyanavel XR, INGREZZA, Jornay PM, REXULTI, VRAYLAR, LOREEV XR, VIVITROL.
Industry payments across NC — which companies pay providers there.
